Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes

J Diabetes Complications. 2023 Sep;37(9):108583. doi: 10.1016/j.jdiacomp.2023.108583. Epub 2023 Aug 2.

Abstract

We found that individuals in the top tertile of HOMA-IR and with HbA1c-defined prediabetes have elevated risk of cardiometabolic outcomes.

Keywords: Biomarkers; Cardiometabolic disease; Insulin resistance; Prediabetes; Prospective cohort.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biomarkers
  • Blood Glucose
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / etiology
  • Humans
  • Hyperglycemia* / diagnosis
  • Hyperglycemia* / prevention & control
  • Insulin Resistance*
  • Prediabetic State* / complications
  • Prediabetic State* / diagnosis
  • Prediabetic State* / epidemiology
  • Prognosis

Substances

  • Biomarkers
  • Blood Glucose